Effects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells

Recent studies suggest that of the molecules postulated to function as inhibitors of the NADPH oxidase family of enzymes iodonium analogs known to broadly interfere with flavin dehydrogenase function demonstrate mechanistic validity as NADPH oxidase poisons. In recent work, we have produced a series...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Krishnendu K. Roy, Jiamo Lu, James H. Doroshow
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6a3cd61b61f64ff9b21232b640560c7b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6a3cd61b61f64ff9b21232b640560c7b
record_format dspace
spelling oai:doaj.org-article:6a3cd61b61f64ff9b21232b640560c7b2021-11-25T16:27:54ZEffects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells10.3390/antiox101117572076-3921https://doaj.org/article/6a3cd61b61f64ff9b21232b640560c7b2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1757https://doaj.org/toc/2076-3921Recent studies suggest that of the molecules postulated to function as inhibitors of the NADPH oxidase family of enzymes iodonium analogs known to broadly interfere with flavin dehydrogenase function demonstrate mechanistic validity as NADPH oxidase poisons. In recent work, we have produced a series of novel iodonium compounds as putative inhibitors of these oxidases. To evaluate the potential utility of two novel molecules with favorable chemical properties, NSC 740104 and NSC 751140, we compared effects of these compounds to the two standard inhibitors of this class, diphenyleneiodonium and di-2-thienyliodonium, with respect to antiproliferative, cell cycle, and gene expression effects in human colon cancer cells that require the function of NADPH oxidase 1. Both new agents blocked NADPH oxidase-related reactive oxygen production, inhibited tumor cell proliferation, produced a G1/S block in cell cycle progression, and inhibited NADPH oxidase 1 expression at the mRNA and protein levels at low nM concentrations in a fashion similar to or better than the parent molecules. These studies suggest that NSC 740104 and NSC 751140 should be developed further as mechanistic tools to better understand the role of NADPH oxidase inhibition as an approach to the development of novel therapeutic agents for colon cancer.Krishnendu K. RoyJiamo LuJames H. DoroshowMDPI AGarticleNADPH oxidase 1 (NOX1)diphenyleneiodonium (DPI)di-2-thienyliodonium (DTI)reactive oxygen species (ROS)superoxide (O<sub>2</sub><sup>●</sup><sup>−</sup>)hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)Therapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1757, p 1757 (2021)
institution DOAJ
collection DOAJ
language EN
topic NADPH oxidase 1 (NOX1)
diphenyleneiodonium (DPI)
di-2-thienyliodonium (DTI)
reactive oxygen species (ROS)
superoxide (O<sub>2</sub><sup>●</sup><sup>−</sup>)
hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)
Therapeutics. Pharmacology
RM1-950
spellingShingle NADPH oxidase 1 (NOX1)
diphenyleneiodonium (DPI)
di-2-thienyliodonium (DTI)
reactive oxygen species (ROS)
superoxide (O<sub>2</sub><sup>●</sup><sup>−</sup>)
hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>)
Therapeutics. Pharmacology
RM1-950
Krishnendu K. Roy
Jiamo Lu
James H. Doroshow
Effects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells
description Recent studies suggest that of the molecules postulated to function as inhibitors of the NADPH oxidase family of enzymes iodonium analogs known to broadly interfere with flavin dehydrogenase function demonstrate mechanistic validity as NADPH oxidase poisons. In recent work, we have produced a series of novel iodonium compounds as putative inhibitors of these oxidases. To evaluate the potential utility of two novel molecules with favorable chemical properties, NSC 740104 and NSC 751140, we compared effects of these compounds to the two standard inhibitors of this class, diphenyleneiodonium and di-2-thienyliodonium, with respect to antiproliferative, cell cycle, and gene expression effects in human colon cancer cells that require the function of NADPH oxidase 1. Both new agents blocked NADPH oxidase-related reactive oxygen production, inhibited tumor cell proliferation, produced a G1/S block in cell cycle progression, and inhibited NADPH oxidase 1 expression at the mRNA and protein levels at low nM concentrations in a fashion similar to or better than the parent molecules. These studies suggest that NSC 740104 and NSC 751140 should be developed further as mechanistic tools to better understand the role of NADPH oxidase inhibition as an approach to the development of novel therapeutic agents for colon cancer.
format article
author Krishnendu K. Roy
Jiamo Lu
James H. Doroshow
author_facet Krishnendu K. Roy
Jiamo Lu
James H. Doroshow
author_sort Krishnendu K. Roy
title Effects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells
title_short Effects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells
title_full Effects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells
title_fullStr Effects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells
title_full_unstemmed Effects of Iodonium Analogs on Nadph Oxidase 1 in Human Colon Cancer Cells
title_sort effects of iodonium analogs on nadph oxidase 1 in human colon cancer cells
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6a3cd61b61f64ff9b21232b640560c7b
work_keys_str_mv AT krishnendukroy effectsofiodoniumanalogsonnadphoxidase1inhumancoloncancercells
AT jiamolu effectsofiodoniumanalogsonnadphoxidase1inhumancoloncancercells
AT jameshdoroshow effectsofiodoniumanalogsonnadphoxidase1inhumancoloncancercells
_version_ 1718413142152708096